MDT

Medtronic plc

Health CareS&P 500

Medtronic plc insider trading

Medtronic plc files with the SEC as a Electromedical & Electrotherapeutic Apparatus company headquartered in Galway. Every time one of its executives or directors buys or sells the stock, the filing appears here the moment it reaches the SEC — with grants and option exercises set apart from the trades that cost the insider their own money.

From SEC filings

Recent MDT insider transactions

2 insiders traded MDT on the open market between Jun 08, 2026 and Sep 16, 2026 — 4 sales worth $733.8K, of which one was pre-scheduled under a 10b5-1 plan.

Bought
—
Sold
$733.8K

1 of 4 on a 10b5-1 plan

Net
−$733.8K
Insiders
2

Open-market purchases (code P) and sales (code S) from Medtronic plc's own SEC Form 4 filings. Grants and option exercises are excluded — they are compensation, not decisions. Share counts are derived from the reported value and price. Verify any figure against the original filing before acting on it; this is monitoring, not advice.

Filing history last read from EDGAR on Sep 21, 2026. The live dashboard shows new filings the moment they clear.

Every MDT Form 4 on SEC.gov

SEC Form 4 data, Q3 2024 to Q2 2026

MDT insider trading by quarter

Between Jul 01, 2024 and Jun 30, 2026, 4 insiders traded MDT on the open market: 2 purchases worth $462.8K and 19 sales worth $11.2M, 3 of the sales pre-scheduled under a 10b5-1 plan. In the last four quarters alone: 2 purchases ($462.8K) and 16 sales ($9.3M), by 3 insiders.

QuarterBoughtSold
Q2 2026—−$337K2 sales
Q1 2026—−$5.1M5 sales
Q4 2025—−$3.1M7 sales
Q3 2025+$462.8K2 buys−$788K2 sales
Q2 2025——
Q1 2025—−$1.9M3 sales · all on a plan
Q4 2024——
Q3 2024——
Largest purchase
+$231.8K of MDT by Jellison William R (Director) on Aug 22, 2025.
Largest sale
−$3M of MDT by Kiil Harry Skip (EVP & President Cardiovascular) on Feb 19, 2026.

Open-market transactions through Jun 30, 2026most recent first

  • Kiil Harry Skip

    EVP & President Cardiovascular

    −$3M

    Feb 19, 2026

    30,568 sh · $97.66

  • Kiil Harry Skip

    EVP & President Cardiovascular

    −$1.9M

    Feb 19, 2026

    19,255 sh · $97.77

  • Kiil Harry Skip

    EVP & President Cardiovascular

    −$161.3K

    Feb 19, 2026

    1,648 sh · $97.86

  • Kiil Harry Skip

    EVP & President Cardiovascular

    −$65.4K

    Feb 19, 2026

    668 sh · $97.83

  • Kiil Harry Skip

    EVP & President Cardiovascular

    −$37.7K

    Feb 19, 2026

    385 sh · $97.82

  • Smith Gregory L

    EVP Global Ops & Supply Chain

    −$2.5M

    Nov 19, 2025

    24,186 sh · $101.93

  • Smith Gregory L

    EVP Global Ops & Supply Chain

    −$203.6K

    Nov 19, 2025

    1,995 sh · $102.03

  • Smith Gregory L

    EVP Global Ops & Supply Chain

    −$198.1K

    Nov 19, 2025

    1,942 sh · $101.99

  • Smith Gregory L

    EVP Global Ops & Supply Chain

    −$84.2K

    Nov 19, 2025

    825 sh · $102.04

  • Smith Gregory L

    EVP Global Ops & Supply Chain

    −$51K

    Nov 19, 2025

    500 sh · $102.08

  • Smith Gregory L

    EVP Global Ops & Supply Chain

    −$33.2K

    Nov 19, 2025

    325 sh · $102.06

  • Smith Gregory L

    EVP Global Ops & Supply Chain

    −$23.2K

    Nov 19, 2025

    227 sh · $102.05

  • Kiil Harry Skip

    EVP & President Cardiovascular

    −$769.7K

    Sep 03, 2025

    8,405 sh · $91.58

  • Kiil Harry Skip

    EVP & President Cardiovascular

    −$18.3K

    Sep 03, 2025

    200 sh · $91.59

  • Jellison William R

    Director

    +$230.9K

    Aug 25, 2025

    2,500 sh · $92.37

From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.

Medtronic plc company record

SEC industry classification
Electromedical & Electrotherapeutic Apparatus
Headquarters
Galway
Listed on
NYSE
SEC Central Index Key
0001613103
Previously filed as
Medtronic Ltd

Sourced from this company's own SEC submissions record. The industry label is SEC's Standard Industrial Classification, which is more specific than the Health Care sector shown above.

After insiders bought MDT

What the stock actually did in the 90 days following each open-market purchase

Don't check MDT — let it ping you

Get told the moment an insider moves on MDT

Pro watches Medtronic plc for you and sends a Telegram ping within moments of a Form 4 clearing EDGAR — a C-suite open-market buy, a cluster, a 10b5-1 regime break — long before it reaches the press. Add MDT to a watchlist, see each mover's benchmark-measured track record and which legendary funds hold it, and read the full filing history instead of the last 72 hours.

The live dashboard is free to open. Alerts, watchlists, full filing history and each mover's benchmark-measured track record are Pro. Monitoring, not advice.

How to read MDT insider activity

Open-market purchase (code P)
An insider spending their own money at market price. This is the only buy code that reliably carries signal — it is a decision, not compensation.
Grants and option exercises (codes A, M)
Scheduled compensation. Most "insider buying" headlines are really this, which is why InsiderPulse weights it at a fraction of a real purchase.
Cluster buy
Two or more different insiders buying on the open market in the same window. One executive buying can mean anything; three is much harder to explain away.

Other Health Care tickers

This week on the tape: who actually chose to sellThe weekly split of scheduled 10b5-1 selling vs deliberate sales, with the deciders named.

Questions

Are MDT insiders buying or selling?
Between Jun 08, 2026 and Sep 16, 2026, 2 Medtronic plc insiders made no open-market purchases and 4 sales worth $733.8K, a net sale of $733.8K. 1 of the sales was pre-scheduled under a Rule 10b5-1 plan.
How much MDT stock have insiders bought and sold in the last two years?
Between Jul 01, 2024 and Jun 30, 2026, 4 Medtronic plc insiders made 2 open-market purchases worth $462.8K and 19 sales worth $11.2M. 3 of the sales were pre-scheduled under a Rule 10b5-1 plan. In the four quarters to Jun 30, 2026: 2 purchases ($462.8K) and 16 sales ($9.3M). The largest purchase was Jellison William R buying $231.8K on Aug 22, 2025. The largest sale was Kiil Harry Skip selling $3M on Feb 19, 2026.
What was the largest recent MDT insider trade?
Kiil Harry Skip (EVP & President Cardiovascular) sold $318.6K of MDT stock on Jun 08, 2026 at about $80.44 a share.
When did an insider last buy MDT shares?
No open-market purchase by a Medtronic plc insider appears in the filings from Jun 08, 2026 to Sep 16, 2026 — every recorded open-market transaction in that period was a sale. Before that, the most recent purchase in SEC's data was Jellison William R buying $230.9K on Aug 25, 2025.
Where does MDT insider trading data come from?
From the Form 4 filings Medtronic plc's officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.

Get the free Insider Brief

Each weekday evening: the day's biggest open-market insider buys, cluster formations and 10b5-1 plan breaks — in plain English, with grants and routine vesting stripped out. Honest about what the data can and cannot say.

No account needed. One-click unsubscribe.